Preoperative [11C]methionine PET to personalize treatment decisions in patients with lower-grade gliomas.
Gaia NinattiMartina SolliniBeatrice BonoNoemi GozziDaniil FedorovLidija AntunovicFabrizia GelardiPierina NavarriaLetterio S PolitiFederico PessinaArturo ChitiPublished in: Neuro-oncology (2022)
This work highlights the role of preoperative [11C]MET PET in estimating the type of suspected LGGs, assessing tumor extent, and predicting biological behavior and prognosis of histologically confirmed LGGs. Our findings support the implementation of [11C]MET PET in routine clinical practice to better manage these neoplasms.